E-cadherinCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。E-cadherin遺伝子サイレンサーは、E-cadherin CRISPR/Cas9ノックアウトプラスミドとE-cadherinDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のE-cadherinCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
E-cadherin CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
E-cadherin CRISPR/Cas9 KOプラスミド (h) | sc-400031 | h | Gene Knockout | GFP | 3 | ||
E-cadherin HDRプラスミド (h) | sc-400031-HDR | h | Homology Directed Repair | Puromycin | 3 | ||
E-cadherin Double Nickaseプラスミド (h) | sc-400031-NIC | h | Gene Knockout | Puromycin | 3 | ||
E-cadherin Double Nickaseプラスミド (h2) | sc-400031-NIC-2 | h | Gene Knockout | Puromycin | 3 | ||
E-cadherin CRISPR/Cas9 KOプラスミド (m2) | sc-419587-KO-2 | m | Gene Knockout | GFP | 0 | ||
E-cadherin HDRプラスミド (m2) | sc-419587-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
E-cadherin Double Nickaseプラスミド (m) | sc-419587-NIC | m | Gene Knockout | Puromycin | 0 | ||
E-cadherin Double Nickaseプラスミド (m2) | sc-419587-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
E-cadherin CRISPR/Cas9 KOプラスミド (canine) | sc-437341 | canine | Gene Knockout | 0 | |||
E-cadherin Double Nickaseプラスミド (canine) | sc-437341-NIC | canine | Gene Knockout | Puromycin | 0 | ||
E-cadherin Double Nickaseプラスミド (canine2) | sc-437341-NIC-2 | canine | Gene Knockout | Puromycin | 0 |
E-cadherin CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
E-cadherin CRISPR Activationプラスミド (h) | sc-400031-ACT | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
E-cadherin CRISPR Activationプラスミド (h2) | sc-400031-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
E-cadherin Lentiviral Activation Particles (h) | sc-400031-LAC | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
E-cadherin Lentiviral Activation Particles (h2) | sc-400031-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 3 | ||
E-cadherin CRISPR Activationプラスミド (m) | sc-419587-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin CRISPR Activationプラスミド (m2) | sc-419587-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin Lentiviral Activation Particles (m) | sc-419587-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin Lentiviral Activation Particles (m2) | sc-419587-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin CRISPR Activationプラスミド (canine) | sc-437341-ACT | canine | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin CRISPR Activationプラスミド (canine2) | sc-437341-ACT-2 | canine | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin Lentiviral Activation Particles (canine) | sc-437341-LAC | canine | Gene Activation | Puro, Blast, Hygro | 0 | ||
E-cadherin Lentiviral Activation Particles (canine2) | sc-437341-LAC-2 | canine | Gene Activation | Puro, Blast, Hygro | 0 |